HHS Convenes Leaders at the Live Real Life Symposium to Address Harms of Screen Use in Children - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

HHS Gathers Experts at the Live Real Life Symposium to Discuss the Impact of Screen Time on Children's Health

  • By

  • Assistant Secretary for Public Affairs (ASPA)

  • September 1, 2026

Share

Clinical Scorecard: Impact of Screen Time on Children's Health

At a Glance

CategoryDetail
ConditionScreen Time Impact on Children
Key MechanismsEffects of screen use on childhood development and health.
Target PopulationChildren and adolescents.
Care SettingPublic health and community initiatives.

Key Highlights

  • HHS convened experts to discuss screen time harms and strategies for healthier development.
  • The Live Real Life initiative aims to reduce harmful screen use.
  • The Magic Tablet book introduces principles of healthy screen use for families.
  • Healthcare providers can earn CE credits for engaging with screen-related harms guidance.

Guideline-Based Recommendations

Diagnosis

  • Assess screen use patterns and their impact on children's health.

Management

  • Implement strategies to promote real-world experiences over screen time.

Monitoring & Follow-up

  • Continuously evaluate children's screen engagement and its effects.

Risks

  • Recognize potential harms associated with excessive screen use.

Patient & Prescribing Data

Children and adolescents experiencing screen-related health issues.

Focus on balancing technology use with real-world interactions.

Clinical Best Practices

  • Engage families in discussions about screen time management.
  • Utilize evidence-based resources to guide screen use recommendations.
  • Collaborate with educators and community leaders to support healthy development.

Related Resources & Content

Original Source(s)

HHS Convenes Leaders at the Live Real Life Symposium to Address Harms of Screen Use in Children

  • by Assistant Secretary for Public Affairs (ASPA)

  • September 1, 2026

Related Content

Pediatric tularemia in Denmark: a forgotten disease

FDA approves XFG-adapted COVID-19 vaccine

The 2026 to 2027 formulation aligns with FDA guidance on the preferred composition for COVID-19 vaccines beginning this fall.

Correction: ACL injuries in skeletally immature athletes